Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00046371
Status:
COMPLETED
Last Update Posted:
2008-01-23
First Post:
2002-09-27
Brief Title:
Safety and Immunological Response Rate Study of THERATOPE Vaccine in Metastatic Breast Cancer Patients
Sponsor:
Oncothyreon Canada Inc
Organization:
Oncothyreon Canada Inc
Organization Data
Organization:
Oncothyreon Canada Inc
Class:
INDUSTRY
Study ID:
STn-BR-105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oncothyreon Canada Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None